Loading video...

Video Failed to Load

Go Home

Dr. Patrick Soon-Shiong just showed Chris Cuomo dramatic before-and-after brain scans of late-stage tumor patients who failed chemo, radiation, and surgery — achieving complete remission with ANKTIVA. No chemo. No radiation. Tumors shrinking dramatically in months. He says: “We got FDA approval to treat patients who failed everything… and...

282,229 views • 6 months ago •via X (Twitter)

35 Comments

Camus's profile picture
Camus6 months ago

Credit: @DrPatrick; @NewsNation;

Holistic Health's profile picture
Holistic Health6 months ago

Very promising. I recommend watching his long form interview with Tucker.

Jeff Boone's profile picture
Jeff Boone6 months ago

Keep this man safe. The drug companies don't like cures, just endless treatments.

freedom🇨🇦's profile picture
freedom🇨🇦6 months ago

I used to follow Patrick until I noticed he never mentions cheap, repurposed drugs like ivermectin, mebendazole, or fenbendazole. This is a red flag for me, but I hope he succeeds and can make Anktiva affordable. Unfortunately, Anktiva is what Scott Adams took shortly before he rapidly deteriorated and died. @MakisMedicine

Berlinergy's profile picture
Berlinergy6 months ago

Yes +check the latest presentation of patient results (before after )here :

Sandy Glass's profile picture
Sandy Glass6 months ago

My daughter needs to have ANKTIVA to help replenish her leukocyte count destroyed by chemo. ANKTIVA non-toxic, studied for over 10 years but FDA slow walking approval. Why?

thedude's profile picture
thedude6 months ago

are you folks insane, lol,, this guy is classic big pharma: Soon-Shiong is the chairman of Chan Soon-Shiong Family Foundation, a non-profit foundation. He has been a minority owner of the Los Angeles Lakers since 2010, and since June 2018, he has been the owner and executive chairman of the Los Angeles Times.[6] Soon-Shiong's net worth is estimated at US$16.6 billion as of 2026 according to the Bloomberg Billionaires Index and Forbes.[7] He has been called the richest man in Los Angeles and one of the wealthiest doctors in the world.[8]

Carlos_Danger's profile picture
Carlos_Danger6 months ago

Why not give this to anyone that's terminal who wants it and use that as trials? My father died from gallbladder cancer. He was late stage 4 when diagnosed. They pumped every poison in his body for six months trying to slow the inevitable. I think it actually sped it up, but we would have gladly taken this if offered.

Chalala🐾🇺🇸's profile picture
Chalala🐾🇺🇸6 months ago

My daughter has brain cancer and has completed radiation and chemo. The chemo has caused her to need three blood transfusions. She should have access to Anktiva. @RobertKennedyJr @US_FDA

Gary's profile picture
Gary6 months ago

@XrpHomie $IBRX If anyone hasn’t seen the @NewsNation @ChrisCuomo interview with @DrPatrick, it’s a must watch. Dr. Patrick has shown amazing results on many cancers-patient testimonies at 40 min mark-Aline and Jim- all current had failed until Anktiva-Miracle🙏

BrianSays's profile picture
BrianSays6 months ago

Lost my mom to brain cancer is 2019. I hope this proves helpful to those suffering from this horrendous disease

Janet Neustedter's profile picture
Janet Neustedter6 months ago

Good information but anything with @ChrisCuomo in it is automatic cringe. He is a tool now and then and has zero credibility

MysteryMavX's profile picture
MysteryMavX6 months ago

Fabulous! It should be available immediately, not just late-stage, nothing else works. Why go through all those horrific treatments if this is better?

Brad C's profile picture
Brad C6 months ago

The @US_FDA needs to allow this in the US. The fact Saudi Arabia is allowing this but we can’t have this treatment in the US. Because big pharma takes priority is ridiculous.

Gary Gerden's profile picture
Gary Gerden6 months ago

@bullishbruk If the medical establishment wasn’t already making billions of the chemotherapy, this treatment would be fast tracked for FDA approval.

Marsha Flewelling's profile picture
Marsha Flewelling6 months ago

Right to Try

DougW's profile picture
DougW6 months ago

Chris Cuomo can kiss my ass! I have detested him since he and his lowlife brother were the biggest supporters of Herr Fauci and the illegal Bribum mandates! I am familiar with the great doctor Dr. Patrick Soon-Shiong but just wish he wouldn't give that bum a second of his time.

Dr. Tamale Henry Duke's profile picture
Dr. Tamale Henry Duke6 months ago

This is groundbreaking! The potential of ANKTIVA could change cancer treatment entirely. Looking forward to more updates on this progress.

Macaroniste's profile picture
Macaroniste6 months ago

Didn't work for Scott Adams, though.

TruthS33ker🐭's profile picture
TruthS33ker🐭6 months ago

Oh my … so much to learn …. Soon-Shiong is so much more than most realize 💥💥🧵👇👇

MP's profile picture
MP6 months ago

A family member received the Anktiva shot. Shortly after, blood test numbers went out of normal range. When they didn't return to normal by the time he was supposed to receive the second shot, they kicked him out of the trial. Surely your success members look good when you immediately remove people who aren't doing well from the program. This family member was currently doing another standard treatment for his cancer and his continues to do well on that without the Anktiva. Hard to believe this is much more than snake oil.

UnitedWeStand-DividedWeFall's profile picture
UnitedWeStand-DividedWeFall6 months ago

Now look into the cost of treatment. Is Not of the cost covered? Millionaires congrats. You found a cure.

SpilDaBeans's profile picture
SpilDaBeans6 months ago

Please explain why people have to go through hell before they can receive Anktiva. Why do patients have to be in late stage?

klemens d's profile picture
klemens d6 months ago

I don't trust the guy as far as I can throw him. I wouldn't be suprised if his super expensive biologicals contained a healthy dose of fenbendazole and ivermectin on the side.

kelly's profile picture
kelly6 months ago

This should be for all stage- Not just late stage!

Jackie Beal's profile picture
Jackie Beal6 months ago

I’m hoping it is a cure but it must not always be as Scott Adams used it and still died

Wendi Strauch Mahoney🇺🇸Persevere.'s profile picture
Wendi Strauch Mahoney🇺🇸Persevere.6 months ago

@WorkAuthority I wonder if it works on multiple myeloma

Bryn Stables 🇳🇿 颜领惠's profile picture
Bryn Stables 🇳🇿 颜领惠6 months ago

Absolutely need larger and longer term trials! Otherwise same issue as Covid vaccine. There is no replacement for time to show harms.

Asbury4040's profile picture
Asbury40406 months ago

Look into the @FLsharkman protocols. It’s the only thing I currently trust.

Cj Stites's profile picture
Cj Stites6 months ago

@megbasham please help her

Sera Aurelia X's profile picture
Sera Aurelia X6 months ago

This guy is a grifter. Many previous similar projects. Caution.

kerrie Tu's profile picture
kerrie Tu6 months ago

How long before this outspken person os gone

Waltz King's profile picture
Waltz King6 months ago

@JRPLawyeress Big Pharma will kill it!

Kathy's profile picture
Kathy6 months ago

I’m stage 4 stomach cancer and I want it now!

Rachel Buckley's profile picture
Rachel Buckley6 months ago

Saudi Arabia allows this treatment so why can't we in the US?

Related Videos

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 views • 8 months ago

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.

Camus

422,251 views • 11 months ago

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,893 views • 1 year ago

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 views • 1 year ago

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 views • 1 year ago